Literature DB >> 15349805

Immunologic mechanisms of alcoholic liver injury.

Geoffrey M Thiele1, Thomas L Freeman, Lynell W Klassen.   

Abstract

Clinically, the association of alcoholic liver disease (ALD) with circulating autoantibodies, hypergammaglobulinemia, antibodies to unique hepatic proteins, and cytotoxic lymphocytes reacting against autologous hepatocytes strongly suggests altered immune regulation with an increased activity toward normal self-proteins (loss of tolerance). Experimentally, there are several immune responses generated specifically recognizing self-proteins that are modified by metabolites of alcohol. These data strongly suggest that immune reactions may play a significant role in inducing and sustaining an inflammatory cascade of tissue damage to the liver. Additional support for this comes from the observation that the histological appearance of livers with ALD is that of a chronic active hepatitis-like inflammatory disease. Therefore, the hypothesis that immune mechanisms are involved in recurrent alcoholic hepatitis, although not summarily proven, is reasonable, supported by clinical and experimental evidence, and the subject of this article.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349805     DOI: 10.1055/s-2004-832940

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  29 in total

1.  Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites.

Authors:  Geoffrey M Thiele; Michael J Duryee; Monte S Willis; Dean J Tuma; Stanley J Radio; Carlos D Hunter; Courtney S Schaffert; Lynell W Klassen
Journal:  Alcohol Clin Exp Res       Date:  2010-09-22       Impact factor: 3.455

Review 2.  Immunological response in alcoholic liver disease.

Authors:  Michael J Duryee; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

3.  Effects of long-term ethanol administration in a rat total enteral nutrition model of alcoholic liver disease.

Authors:  Martin J J Ronis; Leah Hennings; Ben Stewart; Alexei G Basnakian; Eugene O Apostolov; Emanuele Albano; Thomas M Badger; Dennis R Petersen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-04       Impact factor: 4.052

Review 4.  Chronic liver inflammation: clinical implications beyond alcoholic liver disease.

Authors:  Byoung-Jin Park; Yong-Jae Lee; Hye-Ree Lee
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 5.  Alcoholic liver disease: pathogenesis and new therapeutic targets.

Authors:  Bin Gao; Ramon Bataller
Journal:  Gastroenterology       Date:  2011-09-12       Impact factor: 22.682

Review 6.  Pathogenesis and Management of Alcoholic Liver Disease.

Authors:  M Omar Farooq; Ramon Bataller
Journal:  Dig Dis       Date:  2016-05-11       Impact factor: 2.404

Review 7.  Alcoholic liver disease: pathogenesis, management, and novel targets for therapy.

Authors:  Eric S Orman; Gemma Odena; Ramon Bataller
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

Review 8.  Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease.

Authors:  Courtney S Schaffert; Michael J Duryee; Carlos D Hunter; Bartlett C Hamilton; Amy L DeVeney; Mary M Huerter; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 9.  Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Vanessa Teaberry; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

10.  Liv.52 regulates ethanol induced PPARgamma and TNF alpha expression in HepG2 cells.

Authors:  Shankar K Mitra; Sandeep Ravi Varma; Ashok Godavarthi; Krishna S Nandakumar
Journal:  Mol Cell Biochem       Date:  2008-05-01       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.